Tablet (Immediate Release Scored Disc) · Clonidine hydrochloride
Tarvelo
Clonidine hydrochloride in an immediate-release scored tablet (100 mcg). Acts on presynaptic alpha-2A autoreceptors in the brain stem to tone down adrenaline output, calming peripheral tension and stabilizing cardiovascular rhythm without dulling cognitive focus.
- 100 mcg
- Target sympatholytic payload.
- 30-60 min
- Fast onset to settle acute stimulation.
- Balanced
- Normalizes blood pressure and grounds physical restlessness.
Action & Kinetics
Tarvelo selectively stimulates inhibitory alpha-2A adrenergic autoreceptors in the locus coeruleus of the brain stem. By turning down the central firing rate of norepinephrine neurons, it curbs downstream peripheral sympathetic outflow. This selectively reduces excess cardiovascular tension, settles physical jitters, and restores autonomic balance without intoxicating or sedating cognitive processing.
- Active MoleculeClonidine hydrochloride
- Delivery SystemTablet (Immediate Release Scored Disc)
- Nominal Payload100 mcg
- Therapeutic Timing30 to 60 minute onset, 6 to 8 hour duration
Primary Clinical Effects
- Central SympatholysisRapidly dials back the physical edge, muscle tightness, and adrenaline surge associated with high stress or stimulant administration.
- Cardiovascular NormalizationReturns elevated resting blood pressure and pulse to a calm baseline, smoothing out cardiovascular fluctuations.
- Executive GroundingSettles distracting somatic tension, allowing the mind to remain still and focused on critical problem solving.
Secondary Reactions & Cautions
The following physiological responses are documented during active administration:
- Physical Relaxation & LethargyProduces mild drowsiness and limb heaviness, particularly during initial adaptation or when administered while seated.
- Secretomotor ReductionInduces dry mouth (xerostomia) and reduced tear production; easily managed with adequate fluid intake.
- Orthostatic AwarenessTransient lightheadedness when rising rapidly from a prone position due to lowered peripheral resistance.
Administration Protocol: Administer as needed for acute physical stabilization or at bedtime. Must not be abruptly discontinued after prolonged use; taper gradually to avoid rebound blood pressure elevation.
Testing & Sampling Status
Notice: This stuff is real, not fake, and we are currently in the active testing and sampling phase.
All formulations are synthesized and prepared under strict laboratory conditions in Perth, Western Australia. Inquiries for testing dossiers, institutional sampling batches, and analytical specifications should be directed to the engineering team.
Contact hello@caissonai.co or human@caissonai.co for sampling inquiries.